Vsee Health, Inc. (VSEE) Stock Price & Analysis
Vsee Health, Inc. (VSEE) fell 3.07% to USD 0.08 as of July 25, 2026 at 09:10 UTC, according to Nexqual real-time market data.
VSEE last closed at USD 0.08; the session ranged USD 0.08–0.08 on volume of 1,496,163 shares. Market capitalization is $3.84M, with a 52-week range of USD 0.08–2.52 (NCM). Source: Nexqual, July 25, 2026 at 09:10 UTC.
Key Statistics (as of July 25, 2026 at 09:10 UTC)
| Price | USD 0.08 |
|---|---|
| Change | ▼ 3.07% (down) |
| Previous Close | USD 0.08 |
| Open | USD 0.08 |
| Day Range | USD 0.08 – 0.08 |
| 52-Week Range | USD 0.08 – 2.52 |
| Volume | 1,496,163 shares |
| Market Cap | $3.84M |
| Exchange | NCM |
Technical Analysis (VSEE)
Nexqual's technical model rates VSEE "SELL" based on 3 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 09:10 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 23.04 (oversold) |
| vs SMA50 | Below (USD 0.13) |
| MACD | -0.01 (negative) |
Analyst Ratings (VSEE)
Wall Street analysts rate VSEE "None", per Nexqual as of July 25, 2026 at 09:10 UTC.
| Consensus Rating | None |
|---|
Earnings (VSEE)
Source: Nexqual, July 25, 2026 at 09:10 UTC.
Financials & Fundamentals (VSEE)
| Total Revenue | $14.46M |
|---|---|
| Revenue Growth (YoY) | -4.90% |
| Gross Margin | +46.30% |
| Operating Margin | -94.12% |
| Profit Margin | -92.37% |
| ROE | -945.70% |
| Debt / Equity | 33.78 |
| Current Ratio | 0.41 |
| Total Cash | $1.35M |
| Total Debt | $2.14M |
| Free Cash Flow | $-5.38M |
Source: Nexqual, July 25, 2026 at 09:10 UTC.
Financial Health Score (VSEE)
Nexqual rates Vsee Health, Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 09:10 UTC.
| Growth | Weak — Revenue -5% YoY (latest Q), declining |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $1M cash vs $2M debt |
| Cash Flow | Weak — Operating cash flow -$5M |
| Efficiency | Critical — ROE -946%, ROA -34.9% |
Ownership (VSEE)
| Insider Ownership | +14.87% |
|---|---|
| Institutional Ownership | +9.30% |
| Shares Outstanding | 48.60M |
| Float | 37.69M |
| Short % of Float | +4.05% |
Source: Nexqual, July 25, 2026 at 09:10 UTC.
Major Backers & Investors (VSEE)
Notable institutional backers of Vsee Health, Inc. include Armistice Capital, LLC, Fidelity, Cygnus Capital Advisors, LLC, according to Nexqual as of July 25, 2026 at 09:10 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Armistice Capital, LLC | 6.28% |
| Fidelity | 0.71% |
| Cygnus Capital Advisors, LLC | 0.22% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Geode Capital | 0.79% |
| Vanguard Group | 0.76% |
Source: Nexqual, July 25, 2026 at 09:10 UTC.
From Vsee Health, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- For example, the laws of the State of California, in which we operate, are more restrictive than HIPAA, including the provisions of the California Consumer Privacy Act, or CCPA, which went into effect January 1, 2020.
- In addition, we have developed channel customers who incorporate our platform as part of a model that combines on-site staffing solutions with telemedicine   The direct sales organization is supported by marketing and customer success specialists.
- Setting up telehealth is often a complex experience, but our system allows fast setup and go live by which healthcare providers can:                       VSee supports efficient team coordination by allowing healthcare providers to:           4 Table of Contents   Our Administrative Features .
- We have developed a comprehensive quality management program that supports evidence-based practices, tracks customer satisfaction levels and encourages continuous improvement of telemedicine services.
Partnerships
- We have developed a unique quality control program in collaboration with each hospital by development of a hospital specific reporting dashboard to monitor and achieve high quality critical care quality.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BENF | Beneficient | USD 3.25 | ▼ 6.61% |
| SCNX | Scienture Holdings, Inc. | USD 0.37 | ▼ 7.75% |
| AMIX | Autonomix Medical, Inc. | USD 2.92 | ▼ 26.63% |
| XHLD | TEN Holdings, Inc. | USD 1.86 | ▼ 11% |
| MIRA | MIRA Pharmaceuticals, Inc. | USD 0.88 | ▼ 4.98% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 09:10 UTC. This page is informational and not investment advice.